Liposomes |
Ability to carry either, hydrophilic or hydrophobic drugs, biocompatible, biodegradable, stable, possibility of surface functionalization |
Toxic because the drug can be leaked or displaced into the blood stream; High production cost |
[72] |
Polymeric nanoparticles |
Biocompatible, low toxicity, biodegradable, cost-effectives, possible surface functionalization, avoids leakage of the drug |
Difficult to scale up |
[73,74] |
Solid lipid nanoparticles (SLNs) |
Protect drug against harsh environmental conditions, easy scale up, biocompatible |
Low drug-loading efficacy due to its crystalline structure, there is a chance of drug expulsion during the storage of the crystalline structure and initial burst release can occur |
[75,76] |
Nanoemulsions |
Stable, Carry both hydrophobic and lipophilic drugs |
Toxicity of surfactants |
[77] |
Metallic nanoparticles |
Antibacterial, Antifungal properties, Stable, Uniform structure |
Toxicity |
[78] |